Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

Phone: 212-426-7040
madnessofcrowds
madnessofcrowds Mar. 29 at 3:45 PM
$ARKG https://x.com/FT/status/2038214389325521232 just a matter of time...
0 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm Mar. 28 at 6:26 AM
$ARKK We called the top on and shorted many of their names like TDOC(-90% from our entry), U, ARKK, and more. The markets are highly contrarian. (check our profile) We were the only ones in the world that got this right at the top. $ARKF $ARKG $ARKQ $ARKW
0 · Reply
madnessofcrowds
madnessofcrowds Mar. 27 at 8:06 PM
$ARKG they say stocks don't bottom on Fridays. but that close certainly looked like a combination of capitulation/stop losses and big money buying the dip.
0 · Reply
brodobagginz
brodobagginz Mar. 27 at 3:24 PM
$ARKG insane - how much more does biotech actually deserve to be punished like this ? I get its a struggling sector right now but wtf ?
1 · Reply
StocktwitsNews
StocktwitsNews Mar. 27 at 4:11 AM
Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays $TEM $ARKK $ARKG $NVDA $META https://stocktwits.com/news/equity/markets/tempus-ai-stock-near-1-year-low-ark-buys-while-selling-nvidia-meta/cZ3uqlRRIll
0 · Reply
mitch_roy
mitch_roy Mar. 26 at 1:17 PM
$ARKG consolidation
0 · Reply
RockyMontana
RockyMontana Mar. 24 at 4:40 PM
$PSNL inside $ARKG basket continue to be leading.
1 · Reply
wubster_
wubster_ Mar. 23 at 8:16 PM
$ARKG no idea what to do here, I’m down bad on this one
1 · Reply
TalkMarkets
TalkMarkets Mar. 23 at 6:42 PM
What A Dog’s Cancer Reveals About The Future Of #AI $TEM $AZN $ARKG $NVDA https://talkmarkets.com/article/1020110b-4c28-429e-8bf6-7cfb91146f7f
0 · Reply
jaydilks
jaydilks Mar. 23 at 11:12 AM
$ARKG Added pre-market on the news. Lowered Interest Rates.
0 · Reply
Latest News on ARKG
ARKG: Cathie Wood's Biotech Product Is In Rally Mode

Jan 28, 2026, 5:50 PM EST - 2 months ago

ARKG: Cathie Wood's Biotech Product Is In Rally Mode


ARKG: I'm Holding Off Buying For These 3 Reasons

Aug 28, 2025, 8:25 AM EDT - 7 months ago

ARKG: I'm Holding Off Buying For These 3 Reasons


ARKG: April's Wash-Out Low Is Encouraging, Healthcare Still Soft

Jul 25, 2025, 9:43 AM EDT - 8 months ago

ARKG: April's Wash-Out Low Is Encouraging, Healthcare Still Soft


Best Healthcare ETFs To Buy Now

Oct 31, 2024, 2:03 PM EDT - 1 year ago

Best Healthcare ETFs To Buy Now

FXH IXJ VHT XBI XLV


Interest Rate Regimes And ARKG: Underperformance Explained

Oct 8, 2024, 8:00 AM EDT - 1 year ago

Interest Rate Regimes And ARKG: Underperformance Explained


ARKG: A Genomics Play But Active Isn't Adding Value

Jun 24, 2024, 1:07 AM EDT - 1 year ago

ARKG: A Genomics Play But Active Isn't Adding Value


Analyzing ARKG's Trading Activity In Q3

Nov 22, 2023, 11:31 PM EST - 2 years ago

Analyzing ARKG's Trading Activity In Q3


How to Find the Best Biotech ETFs

Oct 30, 2023, 4:52 PM EDT - 2 years ago

How to Find the Best Biotech ETFs

IBB XBI


ARKG ETF: An Enticing Play, But Risks Galore

Sep 28, 2023, 11:15 AM EDT - 2 years ago

ARKG ETF: An Enticing Play, But Risks Galore


Cathie Wood Says ARK Funds Are Seeing Flows Coming Back

Jul 17, 2023, 4:57 PM EDT - 2 years ago

Cathie Wood Says ARK Funds Are Seeing Flows Coming Back

ARKF ARKK ARKW


Can Health Care Stocks Outperform Again In 2023?

Jan 11, 2023, 6:09 PM EST - 3 years ago

Can Health Care Stocks Outperform Again In 2023?

AGNG BBC BBH BBP BMED CNCR FBT


madnessofcrowds
madnessofcrowds Mar. 29 at 3:45 PM
$ARKG https://x.com/FT/status/2038214389325521232 just a matter of time...
0 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm Mar. 28 at 6:26 AM
$ARKK We called the top on and shorted many of their names like TDOC(-90% from our entry), U, ARKK, and more. The markets are highly contrarian. (check our profile) We were the only ones in the world that got this right at the top. $ARKF $ARKG $ARKQ $ARKW
0 · Reply
madnessofcrowds
madnessofcrowds Mar. 27 at 8:06 PM
$ARKG they say stocks don't bottom on Fridays. but that close certainly looked like a combination of capitulation/stop losses and big money buying the dip.
0 · Reply
brodobagginz
brodobagginz Mar. 27 at 3:24 PM
$ARKG insane - how much more does biotech actually deserve to be punished like this ? I get its a struggling sector right now but wtf ?
1 · Reply
StocktwitsNews
StocktwitsNews Mar. 27 at 4:11 AM
Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays $TEM $ARKK $ARKG $NVDA $META https://stocktwits.com/news/equity/markets/tempus-ai-stock-near-1-year-low-ark-buys-while-selling-nvidia-meta/cZ3uqlRRIll
0 · Reply
mitch_roy
mitch_roy Mar. 26 at 1:17 PM
$ARKG consolidation
0 · Reply
RockyMontana
RockyMontana Mar. 24 at 4:40 PM
$PSNL inside $ARKG basket continue to be leading.
1 · Reply
wubster_
wubster_ Mar. 23 at 8:16 PM
$ARKG no idea what to do here, I’m down bad on this one
1 · Reply
TalkMarkets
TalkMarkets Mar. 23 at 6:42 PM
What A Dog’s Cancer Reveals About The Future Of #AI $TEM $AZN $ARKG $NVDA https://talkmarkets.com/article/1020110b-4c28-429e-8bf6-7cfb91146f7f
0 · Reply
jaydilks
jaydilks Mar. 23 at 11:12 AM
$ARKG Added pre-market on the news. Lowered Interest Rates.
0 · Reply
jaydilks
jaydilks Mar. 20 at 6:30 PM
$ARKG is the edgiest of small caps like $IWM . Whenever there’s panic, it’s time to buy. This headline is nudging you to be more aggressive at buying.
0 · Reply
jaydilks
jaydilks Mar. 19 at 2:58 PM
$ARKG The first sector to go down is the first to recover too. ARKG qualifies. Adding heavily.
0 · Reply
charleswindsor111
charleswindsor111 Mar. 18 at 7:54 PM
$ARKG this etf is bleeding in out the ass
1 · Reply
TCLutz
TCLutz Mar. 17 at 11:45 PM
$ORBS <— We have a solid group of retail analysts doing deep dives over here! Come join us! 💪🫡🔥 $WLD.X $ARKG $BMNR $ETH.X
2 · Reply
goinbananas
goinbananas Mar. 17 at 6:19 PM
$OCGN indeed! Looking pretty damn good on the 5 year. Breaking out and gaping up… $ARKG $NVAX $PFE $MRNA
0 · Reply
jaydilks
jaydilks Mar. 17 at 5:11 PM
$ARKG Highlights from ARK’s Big Ideas with companies that do it.
0 · Reply
goinbananas
goinbananas Mar. 17 at 2:26 PM
$QDEL Interesting… $ARKG $LABU $XBI
0 · Reply
hearmyroar
hearmyroar Mar. 17 at 1:29 PM
$ARKG $BMNR $ETH.X $ORBS $WLD.X We will wait and sell together Ma man
0 · Reply
TCLutz
TCLutz Mar. 17 at 1:05 PM
$ORBS NEW Form 4 – Kevin O’Donnell (CEO) Filed: March 17, 2026 Company: Eightco Holdings Inc. (ORBS) Insider: Kevin O’Donnell Role: CEO & Director Transaction date: March 12, 2026 ⸻ What he received • 2,250,000 stock options • Exercise price: $1.01 • Expiration: March 11, 2036 • Underlying shares: 2,250,000 These are options (rights to buy shares) — not shares today. ⸻ Vesting schedule • 25% per year over 4 years • First vest: March 2027 Breakdown: • Year 1 → 562,500 • Year 2 → 562,500 • Year 3 → 562,500 • Year 4 → 562,500 Must remain CEO/director to fully vest. ⸻ What this means economically: If ORBS trades above $1.01, the options gain value. IE: • Stock = $2.00 • Profit per share = $0.99 Total potential value: → ~$2.2M if fully vested & exercised ⸻ Transaction type • Code: “A” (Award) • This is compensation, not a purchase ⸻ Dilution impact If exercised: • Adds 2,250,000 shares Relative to ~200M shares: → ~1.1% potential dilution $WLD.X $ARKG $BMNR $ETH.X
0 · Reply
TCLutz
TCLutz Mar. 17 at 12:50 PM
$ORBS These are excellent/extremely bullish terms for the Form-4: 1. 4,000,000 options were granted • Director Lee Thomas Jong received 4,000,000 stock options. • Exercise price: $1.01 per share. 2. Vesting schedule • Vest 25% per year over four years. • First vesting: March 2027. • Must remain a director to vest. 3. Expiration • Options expire 10 years after grant (2036). If the stock stays below $1.01, the options simply expire worthless. $WLD.X $ARKG $BMNR $ETH.X
2 · Reply
TCLutz
TCLutz Mar. 17 at 12:50 PM
$ORBS Match 16, 5pm: Form 4 – Statement of Changes in Beneficial Ownership Insider: Lee Thomas Jong The filing shows he was granted stock options, not shares: Details: • 4,000,000 stock options • Exercise price: $1.01 per share • Underlying shares: 4,000,000 ORBS • Expiration: March 11, 2036 The options do not vest immediately. They vest: • 25% per year • starting 1 year after the grant date So: • Year 1 → 1,000,000 options vest • Year 2 → another 1,000,000 • Year 3 → another 1,000,000 • Year 4 → final 1,000,000 Important: He must remain a director for them to vest. If ORBS trades above $1.01, the options have value. Example: • Stock = $2.00 • Exercise = $1.01 • Profit per share = $0.99 Potential value if fully vested: $0.99 × 4,000,000 = ~$3.96M This transaction code is “A” (award) — meaning: • Compensation grant • Not an open-market purchase $WLD.X $ARKG $BMNR $ETH.X
0 · Reply
TCLutz
TCLutz Mar. 17 at 12:50 PM
$ORBS BITMINE is positioning ORBS as a strategic partner investment. 💪🫡 Bitmine’s logic is essentially: • Bitmine = ETH treasury + staking platform • ORBS = AI / crypto venture investment vehicle • Both companies share investors (ARK, Kraken ecosystem, etc.). Orbs is the venture capital arm of Bitmine and Bitmine is the war chest treasury! 🔥 $WLD.X $ARKG $BMNR $ETH.X
0 · Reply